4/A: BiomX Inc. Director Russell Greig Corrects Error in Form 4 Filing Regarding Option Acquisition

Director Russell Greig files an amended Form 4 to correct a reporting error regarding the acquisition of derivative securities (options) in BiomX Inc.

Summary

• Russell Greig, a director of BiomX Inc., filed an amendment to a previously submitted Form 4.
• The amendment corrects an error in Table II, Column 5, where the number of derivative securities acquired was incorrectly reported as disposed of (D) instead of acquired (A).
• The transaction involves options to purchase 35,200 shares of BiomX Inc. common stock at an exercise price of $0.538.
• The options vest over four years, with 25% vesting on April 14, 2026, and the remainder vesting in 12 equal quarterly installments over three years.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing correcting a clerical error. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

Form 4 filings are standard practice for company insiders (directors, officers, and 10% owners) to report transactions in their company's securities to the SEC, ensuring transparency and preventing insider trading.

Key Dates

Keywords

Form 4, amendment, derivative securities, options, BiomX Inc., Russell Greig, acquisition, vesting